{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:36:39Z","timestamp":1793734599312,"version":"4.6.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS131812"],"award-info":[{"award-number":["R01NS131812"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["DE032394"],"award-info":[{"award-number":["DE032394"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110756"],"award-info":[{"award-number":["W81XWH2110756"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110885"],"award-info":[{"award-number":["W81XWH2110885"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-2210267"],"award-info":[{"award-number":["W81XWH-2210267"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.phrs.2025.107746","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:15:06Z","timestamp":1745500506000},"page":"107746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain"],"prefix":"10.1016","volume":"216","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangsu","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yize","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-3688","authenticated-orcid":false,"given":"Ru-Rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2025.107746_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107746_bib2","first-page":"571","article-title":"Treatment of chemotherapy-induced peripheral neuropathy: systematic review and recommendations","volume":"21","author":"Hou","year":"2018","journal-title":"Pain. Physician"},{"key":"10.1016\/j.phrs.2025.107746_bib3","article-title":"Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer","volume":"2012","author":"Pike","year":"2012","journal-title":"Chemother. Res Pr."},{"issue":"1-3","key":"10.1016\/j.phrs.2025.107746_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","article-title":"Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy","volume":"291","author":"Jaggi","year":"2012","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.phrs.2025.107746_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.expneurol.2006.05.007","article-title":"Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells","volume":"201","author":"Siau","year":"2006","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107746_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/pmt-2018-0020","article-title":"An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy","volume":"8","author":"Boyette-Davis","year":"2018","journal-title":"Pain. Manag"},{"issue":"12","key":"10.1016\/j.phrs.2025.107746_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrneurol.2014.211","article-title":"Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain","volume":"10","author":"Sisignano","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107746_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1634\/theoncologist.2009-S503","article-title":"Pathophysiology and animal models of cancer-related painful peripheral neuropathy","volume":"15","author":"Bennett","year":"2010","journal-title":"Oncologist"},{"issue":"39","key":"10.1016\/j.phrs.2025.107746_bib9","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1523\/JNEUROSCI.1956-15.2015","article-title":"The cancer chemotherapeutic paclitaxel increases human and rodent sensory neuron responses to TRPV1 by activation of TLR4","volume":"35","author":"Li","year":"2015","journal-title":"J. Neurosci."},{"issue":"43","key":"10.1016\/j.phrs.2025.107746_bib10","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1523\/JNEUROSCI.3708-15.2016","article-title":"CD8+\u2009T Cells and endogenous IL-10 are required for resolution of chemotherapy-induced neuropathic pain","volume":"36","author":"Krukowski","year":"2016","journal-title":"J. Neurosci."},{"issue":"35","key":"10.1016\/j.phrs.2025.107746_bib11","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1523\/JNEUROSCI.3257-18.2019","article-title":"Macrophage toll-like receptor 9 contributes to chemotherapy-induced neuropathic pain in male mice","volume":"39","author":"Luo","year":"2019","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107746_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jpain.2016.02.011","article-title":"Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy","volume":"17","author":"Zhang","year":"2016","journal-title":"J. Pain."},{"issue":"7","key":"10.1016\/j.phrs.2025.107746_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","article-title":"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin","volume":"105","author":"Imai","year":"2001","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2025.107746_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ana.20064","article-title":"Pael-R is accumulated in Lewy bodies of Parkinson's disease","volume":"55","author":"Murakami","year":"2004","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107746_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jnc.13168","article-title":"CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation","volume":"134","author":"Tanabe","year":"2015","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.phrs.2025.107746_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051155","article-title":"Mutation in Parkinson disease-associated, G-protein-coupled receptor 37 (GPR37\/PaelR) is related to autism spectrum disorder","volume":"7","author":"Fujita-Jimbo","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2025.107746_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/genes11060694","article-title":"Orphan G Protein Coupled Receptors in Affective Disorders","volume":"11","author":"Watkins","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.phrs.2025.107746_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fgene.2013.00297","article-title":"G protein-linked signaling pathways in bipolar and major depressive disorders","volume":"4","author":"Tomita","year":"2013","journal-title":"Front Genet"},{"issue":"23","key":"10.1016\/j.phrs.2025.107746_bib19","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.0703368104","article-title":"GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs","volume":"104","author":"Marazziti","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107746_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2017.06.006","article-title":"Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination","volume":"358","author":"Smith","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107746_bib21","article-title":"G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.phrs.2025.107746_bib22","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1073\/pnas.1219004110","article-title":"GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin","volume":"110","author":"Meyer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107746_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2005.11.013","article-title":"Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia","volume":"121","author":"Jolivalt","year":"2006","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.phrs.2025.107746_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41589-021-00748-z","article-title":"Orphan receptor GPR37L1 remains unliganded","volume":"17","author":"Ngo","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107746_bib25","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","article-title":"Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes","volume":"176","author":"Serhan","year":"2006","journal-title":"JImmunol"},{"issue":"8","key":"10.1016\/j.phrs.2025.107746_bib26","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib27","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41467-021-21940-8","article-title":"Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice","volume":"12","author":"Bang","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.phrs.2025.107746_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051006","article-title":"Osteocalcin Alleviates Lipopolysaccharide-Induced Acute Inflammation via Activation of GPR37 in Macrophages","volume":"10","author":"Qian","year":"2022","journal-title":"Biomedicines"},{"issue":"22","key":"10.1016\/j.phrs.2025.107746_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214426","article-title":"Inflammation and Infection in Pain and the Role of GPR37","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107746_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113719","article-title":"GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke","volume":"342","author":"Owino","year":"2021","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107746_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115266","article-title":"Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's disease via the prosaposin-GPR37-IL-6 axis","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.107746_bib32","article-title":"GPR37 Activation Alleviates Bone Cancer Pain via the Inhibition of Osteoclastogenesis and Neuronal Hyperexcitability","author":"Wang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"3","key":"10.1016\/j.phrs.2025.107746_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.23928","article-title":"Neuroprotectin\/protectin D1 protects against neuropathic pain in mice after nerve trauma","volume":"74","author":"Xu","year":"2013","journal-title":"Ann. Neurol."},{"issue":"10289","key":"10.1016\/j.phrs.2025.107746_bib34","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib35","doi-asserted-by":"crossref","first-page":"i69","DOI":"10.1093\/bja\/aeq323","article-title":"When does acute pain become chronic?","volume":"105","author":"Voscopoulos","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.phrs.2025.107746_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-018-0012-5","article-title":"Transition to chronic pain: opportunities for novel therapeutics","author":"Price","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41467-019-13839-2","article-title":"Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"issue":"7849","key":"10.1016\/j.phrs.2025.107746_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-020-03151-1","article-title":"STING controls nociception via type I interferon signalling in sensory neurons","volume":"591","author":"Donnelly","year":"2021","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2025.107746_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173537","article-title":"Satellite glial GPR37L1 and its ligand maresin 1 regulate potassium channel signaling and pain homeostasis","volume":"134","author":"Bang","year":"2024","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107746_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbi.2023.04.013","article-title":"Intrathecal administration of conditioned serum from different species resolves Chemotherapy-Induced neuropathic pain in mice via secretory exosomes","volume":"111","author":"Buchheit","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.phrs.2025.107746_bib41","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/nm.3978","article-title":"Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade","volume":"21","author":"Xu","year":"2015","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107746_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.mcb.2021.12.019","article-title":"Methods and protocols for chemotherapy-induced peripheral neuropathy (CIPN) mouse models using paclitaxel","volume":"168","author":"Pennypacker","year":"2022","journal-title":"Methods Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-021-02155-6","article-title":"Oxidative stress induced by NOX2 contributes to neuropathic pain via plasma membrane translocation of PKCepsilon in rat dorsal root ganglion neurons","volume":"18","author":"Xu","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"7149","key":"10.1016\/j.phrs.2025.107746_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107746_bib45","first-page":"441","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"AnnuRevPharmacolToxicol"},{"key":"10.1016\/j.phrs.2025.107746_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphar.2015.00275","article-title":"Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1","volume":"6","author":"Smith","year":"2015","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2025.107746_bib47","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1064-21.2022","article-title":"Meclizine and metabotropic glutamate receptor agonists attenuate severe pain and Ca(2+) activity of primary sensory neurons in chemotherapy-induced peripheral neuropathy","author":"Shannonhouse","year":"2022","journal-title":"J. Neurosci."},{"issue":"44","key":"10.1016\/j.phrs.2025.107746_bib48","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1073\/pnas.1613246113","article-title":"Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain","volume":"113","author":"Sisignano","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.phrs.2025.107746_bib49","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1007\/s12035-018-1136-3","article-title":"Docosanoids Promote Neurogenesis and Angiogenesis, Blood-Brain Barrier Integrity, Penumbra Protection, and Neurobehavioral Recovery After Experimental Ischemic Stroke","volume":"55","author":"Belayev","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107746_bib50","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1194\/jlr.R800068-JLR200","article-title":"Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease","volume":"50","author":"Bazan","year":"2009","journal-title":"J. Lipid Res"},{"issue":"10","key":"10.1016\/j.phrs.2025.107746_bib51","first-page":"2774","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"JClinInvest"},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib52","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12264-017-0132-3","article-title":"Expression and Role of Voltage-Gated Sodium Channels in Human Dorsal Root Ganglion Neurons with Special Focus on Nav1.7, Species Differences, and Regulation by Paclitaxel","volume":"34","author":"Chang","year":"2018","journal-title":"Neurosci. Bull."},{"issue":"632","key":"10.1016\/j.phrs.2025.107746_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj8186","article-title":"Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors","volume":"14","author":"Tavares-Ferreira","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.107746_bib54","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230675","article-title":"CD163+\u2009macrophages monitor enhanced permeability at the blood-dorsal root ganglion barrier","volume":"221","author":"Lund","year":"2024","journal-title":"J. Exp. Med"},{"issue":"13","key":"10.1016\/j.phrs.2025.107746_bib55","doi-asserted-by":"crossref","first-page":"21526","DOI":"10.18632\/oncotarget.15630","article-title":"CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107746_bib56","doi-asserted-by":"crossref","first-page":"T116","DOI":"10.1016\/j.jpain.2013.09.010","article-title":"Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions","volume":"14","author":"Slade","year":"2013","journal-title":"J. Pain."},{"issue":"10","key":"10.1016\/j.phrs.2025.107746_bib57","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.phrs.2025.107746_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem"},{"issue":"42","key":"10.1016\/j.phrs.2025.107746_bib59","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1523\/JNEUROSCI.2443-11.2011","article-title":"Resolving TRPV1- and TNF-\u03b1-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2025.107746_bib60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tins.2011.08.005","article-title":"Emerging roles of resolvins in the resolution of inflammation and pain","volume":"34","author":"Ji","year":"2011","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107746_bib61","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12974-022-02405-1","article-title":"Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury","volume":"19","author":"Wei","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2025.107746_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pharmtox-051921-084047","article-title":"Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch","volume":"63","author":"Ji","year":"2023","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.phrs.2025.107746_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnagi.2020.00084","article-title":"Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37","volume":"12","author":"Zhang","year":"2020","journal-title":"Front Aging Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2025.107746_bib65","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/glia.23480","article-title":"Glio- and neuro-protection by prosaposin is mediated by orphan G-protein coupled receptors GPR37L1 and GPR37","volume":"66","author":"Liu","year":"2018","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.phrs.2025.107746_bib66","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1242\/jcs.176115","article-title":"The Parkinson's-disease-associated receptor GPR37 undergoes metalloproteinase-mediated N-terminal cleavage and ectodomain shedding","volume":"129","author":"Mattila","year":"2016","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.phrs.2025.107746_bib67","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.1096\/fj.201900070R","article-title":"Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice","volume":"33","author":"McCrary","year":"2019","journal-title":"FASEB J."},{"issue":"6312","key":"10.1016\/j.phrs.2025.107746_bib68","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107746_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.conb.2019.11.006","article-title":"Regulation of pain by neuro-immune interactions between macrophages and nociceptor sensory neurons","volume":"62","author":"Chen","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107746_bib70","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuron.2021.02.018","article-title":"Spinal macrophages resolve nociceptive hypersensitivity after peripheral injury","volume":"109","author":"Niehaus","year":"2021","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.phrs.2025.107746_bib71","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jamaoncol.2018.6771","article-title":"Chemotherapy-Induced Peripheral Neuropathy","volume":"5","author":"Brown","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.phrs.2025.107746_bib72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2018.11.016","article-title":"Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture","volume":"694","author":"Livni","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009968","article-title":"The impact of SBF2 on taxane-induced peripheral neuropathy","volume":"18","author":"Cunningham","year":"2022","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.phrs.2025.107746_bib74","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1167\/iovs.13-12075","article-title":"Neuroprotectin D1 restores corneal nerve integrity and function after damage from experimental surgery","volume":"54","author":"Cortina","year":"2013","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107746_bib75","first-page":"287","article-title":"Nerve growth factor induced overgrowth of axotomized superior cervical ganglia in neonatal rats. Similarities and differences with NGF effects in chemically axotomized sympathetic ganglia","volume":"117","author":"Aloe","year":"1979","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.phrs.2025.107746_bib76","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu Rev. Neurosci."},{"issue":"38","key":"10.1016\/j.phrs.2025.107746_bib77","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1523\/JNEUROSCI.2893-04.2004","article-title":"Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization","volume":"24","author":"Zhuang","year":"2004","journal-title":"JNeurosci"},{"issue":"22","key":"10.1016\/j.phrs.2025.107746_bib78","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1523\/JNEUROSCI.3993-14.2015","article-title":"Persistent Nociception Triggered by Nerve Growth Factor (NGF) Is Mediated by TRPV1 and Oxidative Mechanisms","volume":"35","author":"Eskander","year":"2015","journal-title":"J. Neurosci."},{"issue":"6840","key":"10.1016\/j.phrs.2025.107746_bib79","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/35082088","article-title":"Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition","volume":"411","author":"Chuang","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0896-6273(02)00908-X","article-title":"p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia","volume":"36","author":"Ji","year":"2002","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.phrs.2025.107746_bib81","first-page":"417","article-title":"Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha","volume":"121","author":"Woolf","year":"1997","journal-title":"BrJPharmacol"},{"issue":"7","key":"10.1016\/j.phrs.2025.107746_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215906120","article-title":"Self-renewing macrophages in dorsal root ganglia contribute to promote nerve regeneration","volume":"120","author":"Feng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2025.107746_bib83","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1038\/s41467-020-18642-y","article-title":"Satellite glial cells promote regenerative growth in sensory neurons","volume":"11","author":"Avraham","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107746_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2025.01.012","article-title":"GPR37L1 identifies spinal cord astrocytes and protects neuropathic pain after nerve injury","author":"Xu","year":"2025","journal-title":"Neuron"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:55:36Z","timestamp":1782492936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825001719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":84,"alternative-id":["S1043661825001719"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107746","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107746"}}